Oregon Archive

Latest Posts

Oregon measure would post corporate costs for priciest drugs

Prescription drug companies could be forced to divulge development costs for their products in Oregon under a proposal advancing in the state House. Drug companies would be required to disclose the costs for developing, manufacturing, marketing and distributing their most expensive

DEA does not need warrant to subpoena Oregon prescription drug information

A three-member panel of the 9th U.S. Circuit Court of Appeals ruled Monday that the Drug Enforcement Administration does not need a court-ordered warrant to subpoena information from Oregon’s Prescription Drug Monitoring Program. It also found the ACLU should not have